Table 1.
Name | Typing | Resolution | Nomenclature |
---|---|---|---|
Broad serology | Phenotyping (lymphocytotoxicity) | Low | B14 |
Split serology | Phenotyping (lymphocytotoxicity) | Low | B64 B65 |
First-field | Genotyping (PCR SSP) | Low | B*14 |
NMDP code | Genotyping (PCR SSO) | Intermediate | 14:HUJ |
Second-field | Genotyping (Sanger sequencing and/or NGS) | High | B*14:01 B*14:02 |
Note: HLA alleles nomenclature established by the World Health Organization Nomenclature Committee (http://hla.alleles.org/nomenclature/committee.html). Nomenclature is regularly updated. Here, we consider HLA-B*14:01:01 as an example. ‘NMDP codes’ allele codes narrow the list of alleles that must be considered at a given locus by eliminating some possibilities (e.g. B*14:HUJ means that the typing is either B*14:01 or B*14:02). ‘NMDP codes’ are implemented and updated by the NMDP (https://bioinformatics.bethematchclinical.org/hla-resources/allele-codes/allele-code-lists/allele-code-list-in-alphabetical-order/). PCR SSO: sequence specific oligonucleotide. PCR SSP: sequence specific primers (Howell et al., 2010).